Advertisement
Table 1 Patient characteristics and laboratory findings at hospitalization
| Survivor group (n = 189) | cardiac death group (n = 9) | p-value* | |
|---|---|---|---|
| Age (years) | 65 ± 12 | 75 ± 12 | < 0.01 |
| Male, n (%) | 156 (82.5) | 8 (88.9) | NS |
| Body mass index (kg/m2) | 24.3 ± 3.3 | 22.4 ± 2.4 | NS |
| Diabetes mellitus, n (%) | 34 (18.0) | 3 (33.3) | NS |
| Dyslipidemia, n (%) | 152 (80.4) | 7 (77.8) | NS |
| Hypertension, n (%) | 103 (54.5) | 5 (55.6) | NS |
| Current smoker, n (%) | 63 (33.3) | 1 (11.1) | NS |
| Family history of CAD, n (%) | 58 (30.7) | 1 (11.1) | NS |
| Atrial fibrillation, n (%) | 18 (9.5) | 2 (22.2) | NS |
| History of revascularization | |||
| PCI, n (%) | 31 (16.4) | 1 (11.1) | NS |
| CABG, n (%) | 7 (3.7) | 0 (0.0) | NS |
| Systolic blood pressure (mmHg) | 139 ± 26 | 139 ± 36 | NS |
| Diastolic blood pressure (mmHg) | 79 ± 19 | 79 ± 24 | NS |
| Heart rate (/min) | 77 ± 17 | 88 ± 24 | NS |
| LVEF (%) | 56.6 ± 11.7 | 47.7 ± 14.0 | 0.03 |
| Total cholesterol (mg/dl) | 187 ± 43 | 168 ± 43 | NS |
| Triglycerides (mg/dl) | 137 ± 95 | 108 ± 33 | NS |
| HDL-cholesterol (mg/dl) | 46 ± 12 | 41 ± 15 | NS |
| LDL-cholesterol (mg/dl) | 115 ± 39 | 105 ± 28 | NS |
| eGFR (ml/min/1.73 m2) | 81.3 ± 20.4 | 68.1 ± 17.2 | NS |
| Brain natriuretic peptide (pg/ml) | 151 ± 345 | 597 ± 882 | 0.03 |
| Albumin (g/dl) | 4.0 ± 0.5 | 3.6 ± 0.7 | 0.01 |
| Hemoglobin (g/dl) | 14.5 ± 1.7 | 13.0 ± 2.3 | 0.01 |
| Hemoglobin A1c (%) | 5.8 ± 0.5 | 6.2 ± 0.6 | 0.02 |
| 1,5-AG (µg/ml) | 19.2 ± 7.7 | 12.3 ± 5.3 | < 0.01 |
